Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Inner ear implant may boost brain function in balance disorder patients

NCT ID NCT07627087

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a vestibular implant (a device that helps with balance) can improve how people with severe inner ear damage perform tasks like staying upright, navigating, and thinking. About 20 people who already have the implant will be tested with it on and off, and their results will be compared to people without the implant. The goal is to understand if the implant helps with these higher-level brain functions, not to cure the condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. Patients receiving vestibular implants at UNIGE: Their inclusion criteria are defined as follows: * Deaf, scheduled for CI surgery * Minimum of five year history of documented absence of bilateral auditory and vestibular function, based on review of their audiograms and vestibular tests. * Vestibular testing consistent with BVL * No neurologic disease. note: these patients are recruited and implanted by the group at the University of Geneva Hospital (UNIGE) as part of their ongoing research. The study team are not involved in any way with the decision to surgically implant patients with cochlear or vestibular implants, nor are the researchers involved in any way with pre- or post-operative clinical care. The researchers only involvement is to perform the cognitive tests before, during, and after relatively short periods of stimulation using the vestibular implant (VI) 2. Vestibular patients tested at MEE: vestibular testing consistent with unilateral or bilateral vestibular damage. Both aspects of the study share the same exclusion criteria: Exclusion Criteria: * No known neurologic or otologic disease other than the vestibular and auditory deficits noted above. * Pregnancy. Pregnant women and women up to 4 months postpartum will be excluded because of the known effects and unknown potential effects of pregnancy on sensory function. * Body weight \>250 lbs (due to motion device safety limits) * The chronic use of vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic) * Inability to stand or walk unassisted. * Blindness. * Unstable medical condition. * Orthopedic or musculoskeletal injuries/conditions that affect gait or balance. * Ongoing neck or spinal pain/injuries or recent history of neck or spinal surgery * Amputation, musculoskeletal deformity, or significant leg-length discrepancy * A history of severe head trauma. * Any major psychiatric disorder (e.g., psychosis, schizophrenia, panic disorder), not including anxiety or depression. * Severe heart or pulmonary conditions * Active cancer for which chemo-/radiation therapy is being received.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bilateral vestibular loss are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universite de Geneve

    RECRUITING

    Geneva, 1211 Geneva 4, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.